DIAZEPAM INJECTION USP

hikma canada limited🇨🇦 Health Canada

Approval Id: 201a68ad9b29648e
Drug Approval Canada Name: DIAZEPAM INJECTION USP
Product Name: DIAZEPAM INJECTION USP
Status: Dormant
Status Date: 2022-06-10
Original Market Date: 2017-03-16
Din: 02385392
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous , Intramuscular
Schedule: Targeted (CDSA IV)
Ahfs: 28:24.08
Atc Original: N05BA01 DIAZEPAM
Atc Name: n 05 ba 01
Aig Number: 0103614001
Company Name: hikma canada limited
Company Address: 5995 Avebury Road, Suite 804, Mississauga, Ontario, Canada, L5R 3P9

DIAZEPAM

5 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

201a68ad9b29648e

Type

Standard